Your browser doesn't support javascript.
loading
Bortezomib-based therapy for relapsed/refractory multiple myeloma in real-world medical practice.
Terpos, Evangelos; Katodritou, Eirini; de la Rubia, Javier; Hungria, Vania; Hulin, Cyrille; Roussou, Maria; Delforge, Michel; Bries, Greet; Stoppa, Anne-Marie; Aagesen, Jesper; Sargin, Deniz; Belch, Andrew; Ahlberg, Lucia; Diels, Joris; Olie, Robert A; Robinson, Don; Spencer, Mike; Potamianou, Anna; van de Velde, Helgi; Dimopoulos, Meletios A.
Afiliação
  • Terpos E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • Katodritou E; Department of Hematology, Theagenion Cancer Centre, Thessaloniki, Greece.
  • de la Rubia J; Department of Hematology, Hospital Dr Peset, Universidad Católica de Valencia, Valencia, Spain.
  • Hungria V; Department of Hematology, Theagenion Cancer Centre, Thessaloniki, Greece.
  • Hulin C; Service d'hématologie Hopital Haut leveque CHU Bordeaux, Bordeaux, France.
  • Roussou M; Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
  • Delforge M; Department of Hematology, University Hospital Leuven, Leuven, Belgium.
  • Bries G; Department of Hematology, AZ Turnhout, Turnhout, Belgium.
  • Stoppa AM; Département D'Onco-Hématologie, Institut Paoli-Calmettes, Marseilles, France.
  • Aagesen J; Department of Medicine, Ryhov County Hospital, Jönköping, Sweden.
  • Sargin D; Division of Hematology, Department of Internal Medicine, Istanbul University, Istanbul, Turkey.
  • Belch A; Department of Oncology, Cross Cancer Institute, Edmonton, AB, Canada.
  • Ahlberg L; Hematologliniken Universitetssjukhuset, Linköping, Sweden.
  • Diels J; Division of Janssen Pharmaceutica NV, Janssen Research & Development, Beerse, Belgium.
  • Olie RA; Janssen-Cilag AG, Baar, Switzerland.
  • Robinson D; Janssen Global Services, Raritan, New Jersey.
  • Spencer M; Janssen-Cilag UK, High Wycombe, UK.
  • Potamianou A; Janssen-Cilag Pharmaceutical SACI, Athens, Greece.
  • van de Velde H; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts.
  • Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece.
Eur J Haematol ; 101(4): 556-565, 2018 Oct.
Article em En | MEDLINE | ID: mdl-30027641
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article